Trial intelligence / Profile preview

Intra-articular Dexmedetomidine for Chronic Knee Pain

NCT06641206Recruiting

Sponsor
Tanta University
Start
Sep 2024
Primary completion
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Trial of dexmedetomidine in osteoarthritis (OA) (2 arms), sponsored by Tanta University. Primary endpoint: Proportion of patients reporting at least a 50% reduction in pain (measured by Numerical Rating Scale) at 7 months. Started Sep 2024; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT06641206.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06641206.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call